RecruitingPhase 1Phase 2NCT06431165

Effects of Different Doses of Intravenous Lidocaine Infusion on Peri-operative Pain and Incidence of Postoperative Chronic Pain Within ERAS Protocols, a Dose Finding Study.


Sponsor

Cairo University

Enrollment

69 participants

Start Date

Mar 15, 2024

Study Type

INTERVENTIONAL

Summary

This study aimed To investigate the effects of different doses of Intraoperative intravenous lidocaine infusion on intraoperative opioid consumption, perioperative pain control and incidence of postoperative chronic pain.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Patients age between 18 and 65.
  • Patients with ASA I and II status.
  • Patients undergoing open laparotomy surgeries (including open cholecystectomies).

Exclusion Criteria4

  • Patients unable to comprehend the informed consent.
  • Patients on long term pre-operative opioid regimens.
  • Patients with impairment in hepatic or renal functions.
  • Patients who are planned to receive any form of regional block for the surgery.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLidocaine IV

After confirming patient history, type of operation and patient group allocation, standard ASA monitoring will be attached to the patient then the I.V induction of anesthesia will be commenced using standard doses of Propofol \&Tracrium in addition to 1 μg/kg Fentanyl and 1 ml/10 kg from the bolus Lidocaine syringe followed after 3 minutes by endotracheal intubation, then the Lidocaine infusion Syringe will be attached to a separate I.V line at an infusion rate of 1 ml/10 kg/h. The patient will receive 1 gm of I.V paracetamol and the surgery will be allowed to proceed.


Locations(1)

Cairo University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06431165